Neoadjuvant chemoradiotherapy for esophageal cancer: A review of meta-analyses

World Journal of Surgery

Volumn 33, Issue 12, 2009, Pages 2606-2614

  Wijnhoven, Bas P L ^a   Van Lanschot, Jan J B ^a   Tilanus, Hugo W ^a   Steyerberg, Ewout W ^a   Van Der Gaast, Ate ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; ESOPHAGUS TUMOR; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77956082599     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0223-z     Document Type: Review

References (38)

1. Cook DJ, Sackett DL, Spitzer WO (1995) Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 48:167-171
2. Pignon JP, Hill C (2001) Meta-analyses of randomised clinical trials in oncology. Lancet Oncol 2:475-482
3. Jadad AR, Cook DJ, Browman GP (1997) A guide to interpreting discordant systematic reviews. Can Med Assoc J 156:1411-1416
4. LeLorier J, Gregoire G, Benhaddad A et al (1997) Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337:536-542
5. van Meerten E, Muller K, Tilanus HW et al (2006) Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer 94:1389-1394
6. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226-234
7. Fiorica F, Di Bona D, Schepis F et al (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53:925-930
8. Kaklamanos IG, Walker GR, Ferry K et al (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754-761
9. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543
10. Easterbrook PJ, Berlin JA, Gopalan R et al (1991) Publication bias in clinical research. Lancet 337:867-872
11. Moher D, Cook DJ, Eastwood S et al (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Metaanalyses. Lancet 354:1896-1900
12. Egger M, Zellweger-Zahner T, Schneider M et al (1997) Language bias in randomised controlled trials published in English and German. Lancet 350:326-329
13. Gregoire G, Derderian F, Le Lorier J (1995) Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 48:159-163
14. Moher D, Jadad AR, Tugwell P (1996) Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 12:195-208
15. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41:391-393
16. Greer SE, Goodney PP, Sutton JE et al (2005) Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 137:172-177
17. Guller U (2008) Caveats in the interpretation of the surgical literature. Br J Surg 95:541-546
18. Sacks HS, Berrier J, Reitman D et al (1987) Meta-analyses of randomized controlled trials. N Engl J Med 316:450-455
19. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
20. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161-167
21. Burmeister BH, Smithers BM, Gebski V et al (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659-668
22. Badwe RA, Vaidya JS, Bhansali MS (1997) Multimodal therapy for esophageal adenocarcinoma. N Engl J Med 336:374-375; author reply 375-376
23. Wilke H, Fink U (1996) Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. N Engl J Med 335:509-510
24. Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086-1092
25. Pereira B, Gourgou-Bourgade S, Azaria D et al (2008) Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question? J Clin Oncol 26:5133-5134
26. Lee JL, Park SI, Kim SB et al (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15:947-954
27. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669
28. Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992-1000; discussion 1000-1001
29. Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313
30. Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467
31. Thompson SG, Pocock SJ (1991) Can meta-analyses be trusted? Lancet 338:1127-1130
32. Walsh TN (1995) The role of multimodality therapy in improving survival: a prospective randomised trial. In predicting, defining and improving outcomes for oesophageal carcinoma (MD thesis), Dublin: Trinity College, University of Dublin, pp 124-150
33. Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598
34. Steyerberg EW, Neville BA, Koppert LB et al (2006) Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 24:4277-4284
35. Malthaner RA, Wong RK, Rumble RB et al (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2:35
36. Nygaard K, Hagen S, Hansen HS et al (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104-1109; discussion 1110
37. Le Prise E, Etienne PL, Meunier B et al (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779-1784
38. Walsh TN, McDonell CO, Mulligan ED et al (2000) Multimodal therapy versus surgery alone for squamous cell carcinoma of the esophagus: a prospective randomized trial [abstract]. Gastroenterology 118(Suppl 2):1008